Anti-VEGFR2/KDR/CD309 Antibody (Vulinacimab)
Catalog No.
F2086
Anti-VEGFR2/KDR/CD309 Antibody (Vulinacimab)
Featured Products
Vulinacimab (HLX-06) is an anti-VEGFR-2 monoclonal antibody (mAb). Vulinacimab can be used in cancer research. VEGFR-2 is overexpressed in certain tumors and is essential for angiogenesis and the proliferation, survival, migration, and differentiation of endothelial cells.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
2250342-36-8
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
HLX06
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P35968
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
VEGFR2 / KDR / CD309
Please avoid freeze-thaw cycles.